Vaxxinity, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 20.46 million compared to USD 47.65 million a year ago. Basic loss per share from continuing operations was USD 0.16 compared to USD 0.48 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.048 USD | -5.88% | -63.08% | -94.35% |
05-13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index | CI |
05-13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index | CI |
1st Jan change | Capi. | |
---|---|---|
-94.35% | 6.46M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- VAXX Stock
- News Vaxxinity, Inc.
- Vaxxinity, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022